1. Dahl J, Greenson JK. Colon. In: Mills SE. eds. Histology for pathologists. 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2007; 627-648.
2. Baker AM, Gabbutt C, Williams MJ, et al. Crypt fusion as a homeostatic mechanism in the human colon. Gut 2019;68:19861993.
4. Rubio CA. The histologic structure of the large bowel mucosa and the evolution of the three pathways of colonic carcinogenesis in humans and in experimental animals. Recent Stud Dig Syst Anat 2018;3:1-12.
5. Levine DS, Haggitt RC. Normal histology of the colon. Am J Surg Pathol 1989;13:966-984.
6. Senior PV, Pritchett CJ, Sunter JP, Appleton DR, Watson AJ. Crypt regeneration in adult human colonic mucosa during prolonged organ culture. J Anat 1982;134(Pt 3):459-469.
8. Helander HF, Fändriks L. Surface area of the digestive tract: revisited. Scand J Gastroenterol 2014;49:681-689.
10. Davenport JR, Su T, Zhao Z, et al. Modifiable lifestyle factors associated with risk of sessile serrated polyps, conventional adenomas and hyperplastic polyps. Gut 2018;67:456-465.
11. Deb M, Sengupta D, Kar S, et al. Epigenetic drift towards histone modifications regulates CAV1 gene expression in colon cancer. Gene 2016;581:75-84.
14. Rubio CA, Langner C, Schmidt PT. Partial to complete abrogation of the subepithelial macrophage barrier against the gut microbiota in patients with ulcerative colitis and Crohn’s colitis. Histopathology 2018;72:580-587.
15. Bailie L, Loughrey MB, Coleman HG. Lifestyle risk factors for serrated colorectal polyps: a systematic review and meta-analysis. Gastroenterology 2017;152:92-104.
17. Bogaert J, Prenen H. Molecular genetics of colorectal cancer. Ann Gastroenterol 2014;27:9-14.
19. Bargen JA. Rectal and sigmoidal adenomas: potential carcinoma. Gastroenterology 1951;18:138-140.
20. Hamilton SR, Vogelstein B, Kudo S, et al. Carcinoma of the colon and rectum. In: Hamilton SR, Aaltonen LA. eds. World Health Organization Classification of Tumours. Pathology and genetics of tumours of the digestive system. Lyon: IARC Press, 2000:104-119.
21. Schlemper RJ, Riddell RH, Kato Y, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000;47:251255.
23. Sakai E, Fukuyo M, Ohata K, et al. Genetic and epigenetic aberrations occurring in colorectal tumors associated with serrated pathway. Int J Cancer 2016;138:1634-1644.
24. Neuville A, Nicolet C, Meyer N, et al. Histologic characteristics of non-microsatellite-instable colon adenomas correlate with distinct molecular patterns. Hum Pathol 2011;42:244-253.
25. Jackman RJ, Mayo CW. The adenoma-carcinoma sequence in cancer of the colon. Surg Gynecol Obstet 1951;93:327-330.
26. Longacre TA, Fenoglio-Preiser CM. Mixed hyperplastic adenomatous polyps/serrated adenomas: a distinct form of colorectal neoplasia. Am J Surg Pathol 1990;14:524-537.
27. Torlakovic EE, Gomez JD, Driman DK, et al. Sessile serrated adenoma (SSA) vs. traditional serrated adenoma (TSA). Am J Surg Pathol 2008;32:21-29.
28. O’Brien MJ, Gibbons D. The adenoma-carcinoma sequence in colorectal neoplasia. Surg Oncol Clin N Am 1996;5:513-530.
29. O’Brien MJ, Zhao Q, Yang S. Colorectal serrated pathway cancers and precursors. Histopathology 2015;66:49-65.
30. Rubio CA. Colorectal adenomas: time for reappraisal. Pathol Res Pract 2002;198:615-620.
31. Rubio CA, Kis L, Nastic D, Schmidt PT. Microtubular colorectal adenoma an aggressive histologic phenotype with propensity to evolve into invasive carcinoma. ARC J Cancer Sci 2017;3:31-36.
32. Muto T, Kamiya J, Sawada T, et al. Small “flat adenoma” of the large bowel with special reference to its clinicopathologic features. Dis Colon Rectum 1985;28:847-851.
34. Kudo S, Kashida H, Tamura S, Nakajima T. The problem of “flat” colonic adenoma. Gastrointest Endosc Clin N Am 1997;7:8798.
35. Kudo Se, Lambert R, Allen JI, et al. Nonpolypoid neoplastic lesions of the colorectal mucosa. Gastrointest Endosc 2008;68(4 Suppl):S3-S47.
36. Bird RP. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett 1987;37:147-151.
37. Nascimbeni R, Villanacci V, Mariani PP, et al. Aberrant crypt foci in the human colon: frequency and histologic patterns in patients with colorectal cancer or diverticular disease. Am J Surg Pathol 1999;23:1256-1263.
38. Drew DA, Mo A, Grady JJ, et al. Proximal aberrant crypt foci associate with synchronous neoplasia and are primed for neoplastic progression. Mol Cancer Res 2018;16:486-495.
39. Fenoglio-Preiser CM, Noffsinger A. Aberrant crypt foci: a review. Toxicol Pathol 1999;27:632-642.
40. Dolara P, Caderni G, Luceri C. Surrogate endpoint biomarkers for human colon carcinogenesis. Toxicol Lett 2000;112--113:415420.
43. Rubio CA, Schmidt PT. Are non-dysplastic crypts with corrupted shapes the initial recordable histological event in the development of sporadic conventional adenomas? Anticancer Res 2018;38:5315-5320.
44. Rubio CA, Schmidt PT. Crypts with corrupted shapes in nonpolypoid adenomas. Anticancer Res 2019;39:833-838.
46. Rubio CA, Schmidt PT. The normal epithelium of crypts accruing below nonpolypoid adenomas thrives with relocated proliferating cell-domains and p53-up-regulated cells. Anticancer Res 2019;39:4965-4970.
48. Arai T, Kino I. Morphometrical and cell kinetic studies of normal human colorectal mucosa: comparison between the proximal and the distal large intestine. Acta Pathol Jpn 1989;39:725-730.
49. Gonzalez RS, Messing S, Tu X, McMahon LA, Whitney-Miller CL. Immunohistochemistry as a surrogate for molecular subtyping of gastric adenocarcinoma. Hum Pathol 2016;56:16-21.
51. Rubio CA, Rodesjö M, Duvander A, Mathies M, Garberg L, Shetye J. p53 up-regulation during colorectal carcinogenesis. Anticancer Res 2014;34:6973-6979.
53. Zhou L, Zahid M, Anwar MM, et al. Suggestive evidence for the induction of colonic aberrant crypts in mice fed sodium nitrite. Nutr Cancer 2016;68:105-112.
54. Kristiansen E. The role of aberrant crypt foci induced by the two heterocyclic amines 2-amino-3-methyl-imidazo[4,5-f] quinoline (IQ) and 2-amino-1-methyl-6-phenyl-imidazo[4,5b]pyridine (PhIP) in the development of colon cancer in mice. Cancer Lett 1996;110:187-192.
55. Ghirardi M, Nascimbeni R, Villanacci V, Fontana MG, Di Betta E, Salerni B. Azoxymethane-induced aberrant crypt foci and colorectal tumors in F344 rats: sequential analysis of growth. Eur Surg Res 1999;31:272-280.
56. Richards TC. Early changes in the dynamics of crypt cell populations in mouse colon following administration of 1,2-dimethylhydrazine. Cancer Res 1977;37:1680-1685.
58. Wasan HS, Park HS, Liu KC, et al. APC in the regulation of intestinal crypt fission. J Pathol 1998;185:246-255.
60. Rubio CA. Putative stem cells in mucosas of the esophago-gastrointestinal tract. In: Singh SR. eds. Stem cell, regenerative medicine and cancer. New York: Nova Science Publishers Inc, 2010:279-308.